Skip to main
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 45%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc is positioned to capitalize on the favorable 2026 rate update, particularly as many managed care organizations are reducing benefits, while Alignment maintains a competitive advantage due to its Stars funding. The company’s integrated Medicare Advantage-Value-Based Care model is expected to support long-term market share gains and above-average growth rates, enhancing its financial stability. Moreover, the anticipated gross profit per member per month (PMPM) is likely to increase significantly, progressing from the $90-$150 range in the first two years to over $230 PMPM in years three to five, which further solidifies the positive outlook for Alignment Healthcare's stock.

Bears say

Alignment Healthcare Inc faces several challenges that contribute to a negative outlook on its stock. Despite showcasing a lower average daily cost (ADK) during a period of heightened healthcare utilization, the company struggles with data friction among various payors and inconsistency in results from employed or affiliated primary care providers (PCPs), which could hinder overall performance. Furthermore, while the valuation multiple is positioned slightly above the long-term range for peer managed care organizations (MCOs), the reliance on a technology platform and clinical model may not sufficiently mitigate these operational drawbacks, raising concerns over future earnings stability and growth potential.

Alignment Healthcare (ALHC) has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 45% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 11 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.